Botox vs Dysport vs Xeomin vs Jeuveau: Neuromodulator Comparison + Cost Per Unit (2026)
Botox, Dysport, Xeomin, and Jeuveau are the four FDA-approved botulinum toxin type A products on the US market in 2026. All four block neuromuscular signaling at the injection site, but they differ on protein structure, unit potency, onset time, duration, and price. This guide explains what a patient comparing them in a consultation should actually care about, and where the marketing claims around each product fall apart.
- › Four FDA-approved neuromodulators: Botox, Dysport, Xeomin, Jeuveau. All produce comparable cosmetic outcomes.
- › Jeuveau is consistently the cheapest at typical US retail ($9-$14/unit) versus Botox ($14-$20/unit).
- › Dysport uses different units: 1 Botox unit ≈ 2.5-3 Dysport units. Always compare total treatment cost, not per-unit price.
- › Botox is the only one FDA-approved for migraine and severe hyperhidrosis (insurance-coverable indications).
- › Injector skill matters more than which neuromodulator. Pick the injector first.
The Four Products at a Glance
Botox (onabotulinumtoxinA, AbbVie/Allergan): The original. FDA-approved for cosmetic use since 2002. Largest market share by a wide margin. Sold as Botox Cosmetic. Average US retail $14 to $20 per unit.
Dysport (abobotulinumtoxinA, Galderma): FDA-approved 2009. Smaller protein complex, often described as having a slightly faster onset (2-3 days vs 3-7 for Botox). Different unit-to-effect ratio: 1 unit of Botox is approximately equivalent to 2.5-3 units of Dysport. Average US retail $5 to $7 per Dysport unit (looks cheaper per unit, but you need more).
Xeomin (incobotulinumtoxinA, Merz): FDA-approved 2011. "Naked" molecule with no complexing proteins, which theoretically reduces immune resistance over years of repeated use. Average US retail $13 to $18 per unit. 1:1 ratio with Botox.
Jeuveau (prabotulinumtoxinA, Evolus): FDA-approved 2019 specifically for cosmetic use only (the only one without a medical indication). 1:1 with Botox. Average US retail $9 to $14 per unit - marketed as the affordable premium option.
True Cost Comparison: Watch the Unit Conversion
Per-unit pricing is misleading because Dysport uses different units. For a typical glabellar (between eyebrows) treatment, the equivalent doses are:
- Botox: 20 units - Dysport: 50-60 units (2.5-3x conversion) - Xeomin: 20 units - Jeuveau: 20 units
At average US retail pricing for a glabellar treatment: - Botox: 20 units x $17 = $340 - Dysport: 55 units x $6 = $330 - Xeomin: 20 units x $15 = $300 - Jeuveau: 20 units x $11 = $220
Jeuveau is genuinely the cheapest at typical US retail in 2026, often by 20-35 percent. Dysport ends up roughly comparable to Botox once you account for the unit conversion. Xeomin is slightly cheaper than Botox. Manufacturer rewards programs (Alle for Botox, Aspire for Dysport, Xperience for Xeomin, Evolux for Jeuveau) can shift the effective price further.
Onset and Duration Reality
Manufacturer marketing claims: - Dysport: "Faster onset" (2-3 days vs 3-7 for competitors) - Botox: "Predictable, well-studied" (no speed claim because they were first) - Xeomin: "Pure formulation" (immune resistance pitch) - Jeuveau: "Modern Botox" (mostly a price/branding pitch)
Real-world data: - Onset: All four show visible effect by day 3-4 for most patients. Dysport may have a 1-2 day edge in some patients but it is not a major clinical difference. - Peak effect: Day 10-14 for all four. - Duration: 3-4 months for all four in typical cosmetic doses. Some studies suggest Dysport may diffuse slightly more (which can be a feature or a bug depending on the treatment area).
For most patients, the choice between these four products has minimal real impact on the treatment outcome. The injector's skill and dosing pattern matter far more than which neuromodulator they pick.
Immune Resistance: Is Xeomin Really Different?
Xeomin's "naked molecule" pitch is the most-debated marketing claim in the category. The theory: complexing proteins in Botox and Dysport can trigger neutralizing antibody formation over years of repeated injection, reducing effectiveness. Xeomin removes these proteins.
Clinical evidence: - Antibody formation does happen at low rates with all neuromodulators (estimated 1-3 percent over many years of treatment). - Xeomin formulation does have less complexing protein. - Whether this translates to fewer real-world treatment failures over decades is unclear because long-term comparative data is limited.
Practical implication: If you have been treated with Botox or Dysport for 10+ years and notice declining effect, switching to Xeomin is a reasonable next step. For first-time or younger patients, the immune resistance differentiation is not a strong reason to choose Xeomin over the alternatives.
Migraines, Hyperhidrosis, and Off-Label Use
Beyond cosmetic use, neuromodulators have FDA approvals for:
- Botox: Chronic migraine, severe axillary hyperhidrosis (excessive underarm sweating), cervical dystonia, overactive bladder, strabismus, blepharospasm, and more. - Dysport: Cervical dystonia, limb spasticity in adults and children. - Xeomin: Cervical dystonia, blepharospasm, chronic sialorrhea (excessive drooling), spasticity. - Jeuveau: Cosmetic only (no medical indications approved).
For chronic migraine treatment, Botox is the only FDA-approved option, which is the main reason it dominates the medical neuromodulator category. Insurance coverage for medical indications is generally available for the FDA-approved product (Botox for chronic migraine, etc.) but not for off-label use of the other three.
For hyperhidrosis (excessive sweating), Botox is FDA-approved at substantially higher doses than cosmetic use. Cost is high without insurance: $1,000 to $1,500 per session for axillary treatment. Insurance often covers if you have documented severe hyperhidrosis with failed first-line treatments.
How to Choose: Practical Guidance
Choose Botox if: you are using it for migraine or hyperhidrosis (insurance coverage), you have established positive results with Botox specifically, or your injector is most experienced with Botox dosing patterns.
Choose Dysport if: you want slightly faster onset, your treatment area benefits from slightly broader diffusion (some forehead and crow's feet patterns), or your injector's pricing on Dysport is favorable after unit conversion.
Choose Xeomin if: you have been on Botox or Dysport for many years and notice declining effect, or you specifically want the formulation with fewer complexing proteins.
Choose Jeuveau if: you are cost-sensitive, your injector is experienced with Jeuveau, and you have no specific medical indication. Jeuveau is genuinely the cheapest option in most markets without compromising on FDA approval status.
In 2026, the most-overlooked factor in choosing a neuromodulator is the injector. A skilled injector at a $14/unit Botox practice produces better results than a less-experienced injector at $9/unit Jeuveau. Pick the injector first, then accept whichever product they have the most experience with at acceptable pricing.
Common Pricing Traps
Three patterns to avoid when shopping neuromodulator pricing:
Buy-on-units-not-area pricing. Some practices quote $11/unit Jeuveau and then inject 30+ units where 20 would suffice, blowing up the total. Get the total area-based cost in advance, not just the per-unit rate.
Loyalty program inflation. Alle, Aspire, Xperience, and Evolux loyalty programs provide rewards but also lock you into specific products. The rewards can be worth $50-$150 per treatment cycle but may not offset switching to a cheaper alternative.
Med-spa pricing vs dermatologist pricing. Med-spas without on-site MD supervision often run cheapest per unit but vary in injector experience. Dermatology practices typically charge 20-40 percent more but with more consistent injector quality. For first-time patients especially, the dermatology premium is worth it; experienced patients can shop med-spa pricing more aggressively.
Frequently Asked Questions
Which is cheapest, Botox or Dysport or Xeomin or Jeuveau? +
Jeuveau is consistently the cheapest at typical 2026 US retail, often 20-35 percent below Botox. Dysport looks cheap per unit but you need 2.5-3x more units, so total cost comes out comparable to Botox. Xeomin is slightly below Botox.
Which neuromodulator lasts longest? +
All four have similar duration of 3-4 months at typical cosmetic doses. Manufacturer claims of longer duration are not well-supported by independent clinical comparisons.
Is Jeuveau as good as Botox? +
Yes for cosmetic outcomes. Both contain botulinum toxin type A, both are FDA-approved, both produce comparable wrinkle reduction at equivalent doses. Differences in formulation and complexing proteins exist but do not translate to meaningful cosmetic outcome differences for most patients.
Can I switch from Botox to Dysport or Jeuveau? +
Yes, switching is straightforward. No washout period required. Your injector will adjust dosing based on the conversion ratios (Botox 1:1 with Xeomin and Jeuveau; Botox 1 unit ≈ Dysport 2.5-3 units). Most patients can switch without noticeable difference in results.
Does insurance cover Botox? +
Insurance covers Botox for FDA-approved medical indications: chronic migraine (at least 15 headache days per month), severe axillary hyperhidrosis, cervical dystonia, overactive bladder, and others. Insurance does not cover cosmetic Botox or any of the other three products for medical indications they are not FDA-approved for.
How long does Botox take to work? +
Visible effect typically appears 3-7 days after injection, with peak effect at day 10-14. Dysport may show slightly faster onset (2-3 days) in some patients but the difference is minor. Plan injections at least 2 weeks before any event you want the results to be visible for.
What is the average cost of Botox treatment? +
For glabellar (between eyebrow) lines: $250-$400 in most US markets. For full face (forehead + glabellar + crow's feet): $600-$1,200. Med-spa pricing trends 20-30 percent below dermatology practices. Jeuveau and Xeomin run roughly 20 percent below Botox; Dysport approximately equivalent to Botox after unit conversion.
Bottom Line
For most cosmetic patients in 2026 choosing among Botox, Dysport, Xeomin, and Jeuveau, the practical choice comes down to injector experience and total area-based cost rather than product-specific claims. Jeuveau is the consistently cheapest option without sacrificing FDA approval status or efficacy. Botox is necessary for insurance-covered medical indications (migraine, hyperhidrosis). Xeomin is reasonable for long-term Botox patients noticing declining effect. Dysport offers slight onset and diffusion differences but is essentially comparable to Botox at typical doses. Pick your injector first, then accept whichever product they recommend at acceptable pricing.
Sources
- FDA prescribing information for Botox Cosmetic, Dysport, Xeomin, and Jeuveau, current 2026 labels. (Indications and dosing)
- American Society of Plastic Surgeons 2025 cosmetic procedure statistics report. (US procedure volume and cost)
- Field LM. Botulinum toxin type A neuromodulator comparison. Aesthet Surg J, 2024. (Clinical comparison data)